Endocrine therapy and thyroid function in early luminal breast cancer: a controlled longitudinal retrospective analysis - Top-Institutions - MDSpire

Endocrine therapy and thyroid function in early luminal breast cancer: a controlled longitudinal retrospective analysis

  • By

  • Zengwei Li

  • Tingfei Song

  • Yu Zhang

  • Yonghui Wang

  • Hui Sun

  • June 18, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Young Women’s Breast Cancer Study
    Young Women’s Breast Cancer Study

    N/A, N/A

    Key Differentiators

    • Breast Cancer Research

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Breast Cancer

  • #3

    IEO Breast Cancer Cohort
    IEO Breast Cancer Cohort

    Milan, Italy

    Key Differentiators

    • Breast Cancer Research

  • #4

    Weifang People’s Hospital
    Weifang People’s Hospital

    Weifang, Shandong

    Key Differentiators

    • Breast Surgery

  • #5

    Early Breast Cancer Trialists’ Collaborative Group
    Early Breast Cancer Trialists’ Collaborative Group

    N/A, N/A

    Key Differentiators

    • Clinical Trials
    • Breast Cancer

Original Source(s)

Endocrine therapy and thyroid function in early luminal breast cancer: a controlled longitudinal retrospective analysis

  • by Zengwei Li, Tingfei Song, Yu Zhang, Yonghui Wang, Hui Sun

  • June 18, 2026

Related Content

Fusion protein-mediated costimulation in engineered T cells: from intrinsic signaling to tumor microenvironment rewiring

The quiet joy of being an oncologist

Transcriptome-Inferred metabolic subtypes define prognostic and immune ecosystems in osteosarcoma at single-cell resolution